Depressive symptoms are not associated with long-term integrated testosterone concentrations in hair

References

• Akil H, Gordon J, Hen R, Javitch J, Mayberg H, McEwen B, Meaney MJ, Nestler EJ. 2018. Treatment resistant depression: a multi-scale, systems biology approach. Neurosci Biobehav Rev. 84:272–288.
   PubMed Web of Science ®Google Scholar
• Almeida OP, Yeap BB, Hankey GJ, Jamrozik K, Flicker L. 2008. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry. 65(3):283–289.
   PubMed Web of Science ®Google Scholar
• Antonio L, Wu FCW, O’Neill TW, Pye SR, Ahern TB, Laurent MR, Huhtaniemi IT, Lean MEJ, Keevil BG, Rastrelli G, et al. 2016. Low free testosterone is associated with hypogonadal signs and symptoms in men with normal total testosterone. J Clin Endocrinol Metab. 101(7):2647–2657.
   PubMed Web of Science ®Google Scholar
• Asselmann E, Kische H, Haring R, Hertel J, Schmidt C-O, Nauck M, Beesdo-Baum K, Grabe H-J, Pané-Farré CA. 2019. Prospective associations of androgens and sex hormone-binding globulin with 12-month, lifetime and incident anxiety and depressive disorders in men and women from the general population. J Affect Disord. 245:905–911.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. 1999. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab. 84(2):573–577.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Von Mühlen DG, Laughlin GA, Kripke A. 1999. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo study. J Am Geriatr Soc. 47(6):685–691.
   PubMed Web of Science ®Google Scholar
• Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. 2018. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 103(5):1715–1744.
   PubMed Web of Science ®Google Scholar
• Bollen KA, Curran PJ. 2004. Autoregressive latent trajectory (ALT) models a synthesis of two traditions. Sociol Meth Res. 32(3):336–383.
   Web of Science ®Google Scholar
• Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, Gold EB, Randolph JF, Matthews KA. 2010. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women’s Health Across the Nation (SWAN). Arch Gen Psychiatry. 67(6):598–607.
   PubMed Web of Science ®Google Scholar
• Carrier N, Saland SK, Duclot F, He H, Mercer R, Kabbaj M. 2015. The anxiolytic and antidepressant-like effects of testosterone and estrogen in gonadectomized male rats. Biol Psychiatry. 78(4):259–269.
   PubMed Web of Science ®Google Scholar
• Chambers KC, Phoenix CH. 1981. Diurnal patterns of testosterone, dihydrotestosterone, estradiol, and cortisol in serum of rhesus males: relationship to sexual behavior in aging males. Horm Behav. 15(4):416–426.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y. 2018. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 391(10128):P1357–P1366.
   PubMed Web of Science ®Google Scholar
• Colangelo LA, Craft LL, Ouyang P, Liu K, Schreiner PJ, Michos ED, Gapstur SM. 2012. Association of sex hormones and SHBG with depressive symptoms in post-menopausal women: the multi-ethnic study of atherosclerosis. Menopause. 19(8):877–885.
   PubMed Web of Science ®Google Scholar
• Davis SR, van der Mooren MJ, van Lunsen RHW, Lopes P, Ribot C, Ribot J, Rees M, Moufarege A, Rodenberg C, Buch A, et al. 2006. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause. 13(3):387–396.
   PubMed Web of Science ®Google Scholar
• Dettenborn L, Hinkelmann K, Muhtz C, Gao W, Wingenfeld K, Spitzer C, Moritz S, Kirschbaum C, Otte C. 2013. Hair testosterone and visuospatial memory in middle-aged men and women with and without depressive symptoms. Psychoneuroendocrinology. 38(10):2373–2377.
   PubMed Web of Science ®Google Scholar
• Dettenborn L, Kirschbaum C, Gao W, Spitzer C, Roepke S, Otte C, Wingenfeld K. 2016. Increased hair testosterone but unaltered hair cortisol in female patients with borderline personality disorder. Psychoneuroendocrinology. 71:176–179.
   PubMed Web of Science ®Google Scholar
• Dias RS, Kerr-Corrêa F, Moreno RA, Trinca LA, Pontes A, Halbe HW, Gianfaldoni A, Dalben IS. 2006. Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study. Menopause. 13(2):202–211.
   PubMed Web of Science ®Google Scholar
• Fiacco S, Walther A, Ehlert U. 2019. Steroid secretion in healthy aging. Psychoneuroendocrinology. 105:64–78.
   PubMed Web of Science ®Google Scholar
• Fischer S, Ehlert U, Amiel Castro R. 2019. Hormones of the hypothalamic-pituitary-gonadal (HPG) axis in male depressive disorders – a systematic review and meta-analysis. Front Neuroendocrinol. 55:100792.
   PubMed Web of Science ®Google Scholar
• Ford AH, Yeap BB, Flicker L, Hankey GJ, Chubb SAP, Handelsman DJ, Golledge J, Almeida OP. 2016. Prospective longitudinal study of testosterone and incident depression in older men: the Health In Men Study. Psychoneuroendocrinology. 64:57–65.
   PubMed Web of Science ®Google Scholar
• Gao W, Kirschbaum C, Grass J, Stalder T. 2016. LC-MS based analysis of endogenous steroid hormones in human hair. J Steroid Biochem Mol Biol. 162:92–99.
   PubMed Web of Science ®Google Scholar
• Gao W, Stalder T, Foley P, Rauh M, Deng H, Kirschbaum C. 2013. Quantitative analysis of steroid hormones in human hair using a column-switching LC-APCI-MS/MS assay. J Chromatogr B Analyt Technol Biomed Life Sci. 928:1–8.
   PubMed Web of Science ®Google Scholar
• Geniole SN, Bird BM, Ruddick EL, Carré JM. 2017. Effects of competition outcome on testosterone concentrations in humans: an updated meta-analysis. Horm Behav. 92:37–50.
   PubMed Web of Science ®Google Scholar
• Giltay EJ, Enter D, Zitman FG, Penninx BWJH, van Pelt J, Spinhoven P, Roelofs K. 2012. Salivary testosterone: associations with depression, anxiety disorders, and antidepressant use in a large cohort study. J Psychosom Res. 72(3):205–213.
   PubMed Web of Science ®Google Scholar
• Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. 2003. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause. 10(5):390–398.
   PubMed Web of Science ®Google Scholar
• Hammond GL, Wu T-S, Simard M. 2012. Evolving utility of sex hormone-binding globulin measurements in clinical medicine. Curr Opin Endocrinol Diabetes Obes. 19:183–189.
   PubMedGoogle Scholar
• Hayes LD, Sculthorpe N, Herbert P, Baker JS, Hullin DA, Kilduff LP, Grace FM. 2015. Poor levels of agreement between serum and saliva testosterone measurement following exercise training in aging men. Aging Male. 18(2):67–70.
   PubMed Web of Science ®Google Scholar
• Hooper D, Coughlan J, Mullen M. 2008. Structural equation modelling: guidelines for determining model fit. Electronic J Business Res Meth. 6(1):53–60.
   Google Scholar
• Jahangard L, Mikoteit T, Bahiraei S, Zamanibonab M, Haghighi M, Sadeghi Bahmani D, Brand S. 2019. Prenatal and postnatal hair steroid levels predict post-partum depression 12 weeks after delivery. J Clin Med. 8(9):1290.
   Web of Science ®Google Scholar
• Kapoor A, Schultz-Darken N, Ziegler TE. 2018. Radiolabel validation of cortisol in the hair of rhesus monkeys. Psychoneuroendocrinology. 97:190–195.
   PubMed Web of Science ®Google Scholar
• Kische H, Gross S, Wallaschofski H, Grabe HJ, Völzke H, Nauck M, Haring R. 2017. Associations of androgens with depressive symptoms and cognitive status in the general population. PLoS One 12(5):e0177272.
   PubMed Web of Science ®Google Scholar
• Kische H, Pieper L, Venz J, Klotsche J, März W, Koch-Gromus U, Pittrow D, Lehnert H, Silber S, Stalla GK, et al. 2018. Longitudinal change instead of baseline testosterone predicts depressive symptoms. Psychoneuroendocrinology. 89:7–12.
   PubMed Web of Science ®Google Scholar
• Korenman S, Grotts J, Bell D, Elashoff D. 2018. Depression in non-classical hypogonadism in young men. J Endocr Soc. 2(11):1306–1313.
   PubMed Web of Science ®Google Scholar
• Kranz GS, Wadsak W, Kaufmann U, Savli M, Baldinger P, Gryglewski G, Haeusler D, Spies M, Mitterhauser M, Kasper S, et al. 2015. High-dose testosterone treatment increases serotonin transporter binding in transgender people. Biol Psychiatry. 78(8):525–533.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL. 2002. The PHQ-9: a new depression measure. Psychiatr Ann. 32:1–7.
   Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams J. 2001. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 16(9):606–613.
   PubMed Web of Science ®Google Scholar
• Lomax RG, Schumacker RE. 2012. A beginner’s guide to structural equation modeling. 4th ed. New York (NY): Routledge Academic.
   Google Scholar
• Mahmoud R, Wainwright SR, Galea L. 2016. Sex hormones and adult hippocampal neurogenesis: regulation, implications, and potential mechanisms. Front Neuroendocrinol. 41:129–152.
   PubMed Web of Science ®Google Scholar
• Matsuzaka H, Maeshima H, Kida S, Kurita H, Shimano T, Nakano Y, Baba H, Suzuki T, Arai H. 2013. Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls. Int J Psychiatry Med. 46(2):203–221.
   PubMed Web of Science ®Google Scholar
• Miller KK, Perlis RH, Papakostas GI, Mischoulon D, Iosifescu DV, Brick DJ, Fava M. 2009. Low-dose transdermal testosterone augmentation therapy improves depression severity in women. CNS Spectr. 14(12):688–694.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Yadegarfar M, Gill J, Stubbs B. 2016. Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies. BJPsych Open 2(2):127–138.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health UK. 2010. Depression: the treatment and management of depression in adults. Leicester (UK): British Psychological Society.
   Google Scholar
• Penz M, Wekenborg MK, Pieper L, Beesdo-Baum K, Walther A, Miller R, Stalder T, Kirschbaum C. 2018. The Dresden Burnout Study: protocol of a prospective cohort study for the bio-psychological investigation of burnout. Int J Methods Psychiatr Res. 27(2):e1613.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2013. R development core team. RA Lang Environ Stat Comput. 55:275–286.
   Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, et al. 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatry. 163(11):1905–1917.
   PubMed Web of Science ®Google Scholar
• Schneider G, Zitzmann M, Gromoll J, Ladwig KH, Berger K. 2013. The relation between sex hormone levels, the androgen receptor CAGn-polymorphism and depression and mortality in older men in a community study. Psychoneuroendocrinology 38(10):2083–2090.
   PubMed Web of Science ®Google Scholar
• Sjöberg B, De La Torre B, Hedman M, Falkay G, Diczfalusy E. 1979. Circadian variation in systemic hormone levels in healthy men. J Endocrinol Invest. 2(2):131–137.
   PubMed Web of Science ®Google Scholar
• Stalder T, Kirschbaum C. 2012. Brain, behavior, and immunity analysis of cortisol in hair – state of the art and future directions. Brain, Behav Immun. 26(7):1019–1029.
   PubMed Web of Science ®Google Scholar
• T’Sjoen GG, De Vos S, Goemaere S, Van Pottelbergh I, Dierick M, Van Heeringen C, Kaufman J-M. 2005. Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc. 53(4):636–642.
   PubMed Web of Science ®Google Scholar
• van Manen MJG, Wester VL, van Rossum EFC, van den Toorn LM, Dorst KY, de Rijke YB, Wijsenbeek MS. 2019. Scalp hair cortisol and testosterone levels in patients with sarcoidosis. PLoS One 14(6):e0215763.
   PubMed Web of Science ®Google Scholar
• Walther A, Breidenstein J, Miller R. 2019. Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis. JAMA Psychiatry 76(1):31–40.
   PubMed Web of Science ®Google Scholar
• Walther A, Philipp M, Lozza N, Ehlert U. 2016. The rate of change in declining steroid hormones: a new parameter of healthy aging in men? Oncotarget 7(38):60844–60857.
   PubMedGoogle Scholar
• Walther A, Seuffert J. 2020. Testosterone and dehydroepiandrosterone treatment in ageing men: are we all set? World J Mens Health. 38(2):178–190.
   PubMedGoogle Scholar
• Walther A, Tsao C, Pande R, Kirschbaum C, Field E, Berkman L. 2019. Do dehydroepiandrosterone, progesterone, and testosterone influence women’s depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women. Psychoneuroendocrinology. 109:104382.
   PubMed Web of Science ®Google Scholar
• Walther A, Wasielewska JM, Leiter O. 2019. The antidepressant effect of testosterone: an effect of neuroplasticity? Neurol Psychiatry Brain Res. 32:104–110.
   Google Scholar
• Weber B, Lewicka S, Deuschle M, Colla M, Heuser I. 2000. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology. 25(8):765–771.
   PubMed Web of Science ®Google Scholar
• Wennig R. 2000. Potential problems with the interpretation of hair analysis results. Forensic Sci Int. 107(1–3):5–12.
   PubMed Web of Science ®Google Scholar
• Westley CJ, Amdur RL, Irwig MS. 2015. High rates of depression and depressive symptoms among men referred for borderline testosterone levels. J Sex Med. 12(8):1753–1760.
   PubMed Web of Science ®Google Scholar
• Wierman ME, Arlt W, Basson R, Davis SR, Miller KK, Murad MH, Rosner W, Santoro N. 2014. Androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 99(10):3489–3510.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2017. Depression and other common mental disorders global health estimates. Geneva (Switzerland): WHO.
   Google Scholar
• Wu FCW, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O’Neill TW, Bartfai G, Casanueva FF, Forti G, et al. 2010. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 363(2):123–135.
   PubMed Web of Science ®Google Scholar